Hepatic ablation for neuroendocrine tumor metastases Journal Article
| Authors: | Maithel, S. K.; Fong, Y. |
| Article Title: | Hepatic ablation for neuroendocrine tumor metastases |
| Abstract: | The indolent nature of neuroendocrine tumors and their proclivity to be hormonally active warrant aggressive treatment for advanced stage disease with hepatic metastases. Cytoreduction has been associated with improved symptom control as well as prolonged survival compared with those treated with medical therapy. The primary modalities of cytoreduction employed are resection, ablation, and embolization. In particular, radiofrequency ablation has been utilized with good results and minimal morbidity for treating patients with advanced neuroendocrine disease. © 2009 Wiley-Liss, Inc. |
| Keywords: | cancer survival; treatment response; surgical technique; survival rate; disease course; review; cancer recurrence; artificial embolism; liver neoplasms; cancer staging; cytoreductive surgery; metastasis; quality of life; tumor volume; bleeding; incidence; morbidity; neuroendocrine tumor; lung embolism; acute kidney failure; liver metastasis; patient safety; surgical mortality; cytoreduction; tumor growth; radiofrequency ablation; hepatic metastases; catheter ablation; hepatic ablation; neuroendocrine tumors |
| Journal Title: | Journal of Surgical Oncology |
| Volume: | 100 |
| Issue: | 8 |
| ISSN: | 0022-4790 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2009-12-15 |
| Start Page: | 635 |
| End Page: | 638 |
| Language: | English |
| DOI: | 10.1002/jso.21196 |
| PUBMED: | 20017158 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 1" - "Export Date: 30 November 2010" - "CODEN: JSONA" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work